Aytu BioPharma (AYTU) to Release Quarterly Earnings on Thursday

Aytu BioPharma (NASDAQ:AYTU) is set to announce its earnings results after the market closes on Thursday, September 26th.

Aytu BioPharma Trading Up 2.1 %

Shares of NASDAQ AYTU opened at $2.43 on Wednesday. The business’s 50 day moving average is $2.54 and its 200-day moving average is $2.83. The firm has a market cap of $14.51 million, a P/E ratio of -0.92 and a beta of -1.43. Aytu BioPharma has a 1-year low of $1.55 and a 1-year high of $3.50.

About Aytu BioPharma

Aytu Biopharma, Inc, a commercial-stage pharmaceutical company, focuses on commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company operates through two segments: Rx segment and Consumer Health segment. The Rx segment offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT for patients from six years and older, and Cotempla XR-ODT for patients from six to seventeen years old.